Brief: Kiora Pharmaceuticals Inc Appointed Michael Meluzio As Company's Principal Financial Officer
28/02/2022 22:47
Feb 28 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS INC - APPOINTED MICHAEL MELUZIO,
CPA,
CORPORATE CONTROLLER OF COMPANY, AS COMPANY'S PRINCIPAL
FINANCIAL OFFICER
Further company coverage: KPRX.O
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing